← Back to Search

Y-Balance Test for Predicting Concussion Risk

N/A
Recruiting
Research Sponsored by Arkansas Colleges of Health Education
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Must not have
History of seizure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether the YBT-LQ is predictive of concussion in high school athletes, and whether visual perturbations have an effect on the Y-balance and its injury prevention capability.

Who is the study for?
This trial is for high school athletes, grades 9-12, who play sports either through their school or a club. Middle school students from grades 6-8 may also join if requested by the school or organization. Athletes with a history of seizures cannot participate.
What is being tested?
The study is testing whether the Y Balance Test (YBT-LQ), which measures dynamic balance, can predict concussions in athletes. It includes standard YBT-LQ and an additional version with visual disturbances to see if they affect concussion prediction or lower extremity injury risk.
What are the potential side effects?
Since this trial involves physical performance tests rather than medication, there are no direct side effects like those associated with drugs. However, participants might experience fatigue or muscle soreness as a result of the balance tests.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had seizures in the past.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Report of concussion in past year
Report of lower extremity injury in past year

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Standard Y BalanceActive Control1 Intervention
Subjects will perform Y-balance lower quarter
Group II: Y Balance Plus Stroboscopic GlassesActive Control1 Intervention
Subjects will perform Y-balance lower quarter with and without stroboscopic lenses

Find a Location

Who is running the clinical trial?

Arkansas Colleges of Health EducationLead Sponsor
6 Previous Clinical Trials
236 Total Patients Enrolled

Media Library

Standard Y Balance Clinical Trial Eligibility Overview. Trial Name: NCT05344703 — N/A
Concussion Research Study Groups: Standard Y Balance, Y Balance Plus Stroboscopic Glasses
Concussion Clinical Trial 2023: Standard Y Balance Highlights & Side Effects. Trial Name: NCT05344703 — N/A
Standard Y Balance 2023 Treatment Timeline for Medical Study. Trial Name: NCT05344703 — N/A
~231 spots leftby Aug 2025